Clinical Trial Update: An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)

View source ↗

Summary

Completed observational real-world study (BCARE) evaluating how dermatological toxicities from adjuvant endocrine therapy for early breast cancer impact quality…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Early Breast Cancer, Skin Condition | Status: COMPLETED